Influenza vaccination and risk of stroke: Self-controlled case-series study

Vaccine

Volumn 33, Issue 41, 2015, Pages 5458-5463

  Asghar, Zahid ^a   Coupland, Carol ^b   Siriwardena, Niroshan ^c  

^a UNIVERSITY OF LINCOLN   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Influenza; Influenza vaccination; Self controlled case series method; Stroke; Transient ischaemic attack

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; ADVERSE EFFECTS; AGED; IMMUNIZATION; STROKE; TIME FACTOR; VACCINATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFLUENZA VACCINES; MALE; RISK; STROKE; TIME FACTORS; VACCINATION;

EID: 84941878445     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.08.013     Document Type: Article

References (37)

1. Carroll K., Murad S., Eliahoo J., Majeed A. Stroke incidence and risk factors in a population-based cohort study 2001, vol. 12. Office of National Statistics, Office of National Statistics Health Statistics Quarterly, London.
2. Emsley H.C., Hopkins S.J. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008, 7:341-353.
3. Guiraud V., Amor M.B., Mas J.L., Touze E. Triggers of ischemic stroke: a systematic review. Stroke 2010, 41:2669-2677.
4. Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., Miller M.A. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 2004, 160:492-502.
5. Field T.S., Zhu H., Tarrant M., Mitchell J.R., Hill M.D. Relationship between supra-annual trends in influenza rates and stroke occurrence. Neuroepidemiology 2004, 23:228-235.
6. Brassard P., Bourgault C., Brophy J., Kezouh A., Suissa S. Antibiotics in primary prevention of stroke in the elderly. Stroke 2003, 34:e163-e166.
7. Cooper N.J., Sutton A.J., Abrams K.R., Wailoo A., Turner D., Nicholson K.G. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ 2003, 326:1235.
8. Lavallee P., Perchaud V., Gautier-Bertrand M., Grabli D., Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002, 33:513-518.
9. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003, 348:1322-1332.
10. Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004, 351:2611-2618.
11. Grau A.J., Fischer B., Barth C., Ling P., Lichy C., Buggle F. Influenza vaccination is associated with a reduced risk of stroke. Stroke 2005, 36:1501-1506.
12. Vila-Corcoles A., Ochoa-Gondar O., Rodriguez-Blanco T., et al. Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up. BMC Public Health 2012, 12:222.
13. Hung I.F., Leung A.Y., Chu D.W., et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study. Clin Infect Dis 2010, 51:1007-1016.
14. Pinol-Ripoll G., de la Puerta I., Santos S., Purroy F., Mostacero E. Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination. Cerebrovasc Dis 2008, 26:339-347.
15. Clayton T.C., Thompson M., Meade T.W. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J 2008, 29:96-103.
16. Tseng H.F., Slezak J.M., Quinn V.P., Sy L.S., Van den Eeden S.K., Jacobsen S.J. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA 2010, 303:1699-1706.
17. Johnstone J., Loeb M., Teo K.K., et al. Influenza vaccination and major adverse vascular events in high-risk patients. Circulation 2012, 126:278-286.
18. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006, 35:337-344.
19. Jackson L.A., Nelson J.C., Benson P., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 2006, 35:345-352.
20. Siriwardena A.N., Asghar Z., Coupland C.C. Influenza and pneumococcal vaccination and risk of stroke or transient ischaemic attack-matched case control study. Vaccine 2014, 32:1354-1361.
21. Whitaker H.J., Farrington C.P., Spiessens B., Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006, 25:1768-1797.
22. Whitaker H. The self controlled case series method. BMJ 2008, 337:a1069.
23. Gwini S.M., Coupland C.A., Siriwardena A.N. The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study. Vaccine 2011, 29:1145-1149.
24. Walley T., Mantgani A. The UK general practice research database. Lancet 1997, 350:1097-1099.
25. Jick S.S., Kaye J.A., Vasilakis-Scaramozza C., et al. Validity of the general practice research database. Pharmacotherapy 2003, 23:686-689.
26. Tata L.J., West J., Harrison T., Farrington P., Smith C., Hubbard R. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?. Thorax 2003, 58:835-839.
27. Musonda P., Farrington C.P., Whitaker H.J. Sample sizes for self-controlled case series studies. Stat Med 2006, 25:2618-2631.
28. Kunzel W., Glathe H., Engelmann H., Van H.C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 1996, 14:1108-1110.
29. Schulz K.F., Grimes D.A. Case-control studies: research in reverse. Lancet 2002, 359:431-434.
30. Nicholas J.M., Grieve A.P., Gulliford M.C. Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case-control designs. J Clin Epidemiol 2012, 65:384-393.
31. Siriwardena A.N., Gwini S.M., Coupland C.A. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ 2010, 182:1617-1623.
32. Skowronski D.M., Tweed S.A., De S.G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?. J Infect Dis 2008, 197:490-502.
33. Lehr H.A., Sagban T.A., Ihling C., et al. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 2001, 104:914-920.
34. Ravnskov U., McCully K.S. Infections may be causal in the pathogenesis of atherosclerosis. Am J Med Sci 2012, 344:391-394.
35. Keller T.T., van der Meer J.J., Teeling P., et al. Selective expansion of influenza A virus-specific T cells in symptomatic human carotid artery atherosclerotic plaques. Stroke 2008, 39:174-179.
36. Fiore A.E., Shay D.K., Broder K., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008, 57:1-60.
37. Dexter L.J., Teare M.D., Dexter M., Siriwardena A.N., Read R.C. Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice. BMJ Open 2012, 2:e000851.